SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-043535
Filing Date
2021-03-30
Accepted
2021-03-30 06:01:55
Documents
16
Period of Report
2021-03-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218984d2_8k.htm   iXBRL 8-K 25518
2 EXHIBIT 99.1 tm218984d2_ex99-1.htm EX-99.1 21963
6 GRAPHIC tm218984d2_ex99-1img01.jpg GRAPHIC 5263
7 GRAPHIC tm218984d2_ex99-1img02.jpg GRAPHIC 6716
8 GRAPHIC tm218984d2_ex99-1img03.jpg GRAPHIC 1739
  Complete submission text file 0001104659-21-043535.txt   249709

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20210330.xsd EX-101.SCH 3211
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20210330_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20210330_pre.xml EX-101.PRE 22727
9 EXTRACTED XBRL INSTANCE DOCUMENT tm218984d2_8k_htm.xml XML 3729
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 21783501
SIC: 2834 Pharmaceutical Preparations